DORDA, led by Lukas Herrmann (Partner) and Bernhard Rieder (Partner), supported by Denise Runceanu (Principal Associate) and Bianca Schamberger (Associate), advised the global provider of ophthalmic technologies Topcon Group on the acquisition of all shares in RetInSight GmbH. Topcon Group had already acquired the first shares in RetInSight in 2022 and thus became a shareholder in 2024. In 2025, Topcon ultimately acquired the remaining shares - a strategic step to further strengthening its position in the field of AI-supported diagnostic solutions for ophthalmology.
RetInSight is a digital health company developing transformative retinal AI solutions aimed at improve patient outcomes, enhancing clinical efficiency and reduce healthcare costs. With its comprehensive artificial intelligence solutions, the company enables ophthalmologists, healthcare professionals, academic institutions and the eye care industry to reshape clinical care. By combining advanced technologies from computer science with leading clinical and medical expertise, the company is ideally positioned to shape the future of digital precision medicine.
Topcon Healthcare, Inc. is an U.S. based company and leading provider of digital healthcare solutions with a focus on the sale of ophthalmological diagnostic devices and an indirect subsidiary of the publicly listed Topcon Corporation. The Japanese Topcon Corporation serves as the parent company of a global group specialising in precision technology for healthcare, agriculture and infrastructure. Topcon Healthcare, Inc. achieved a global turnover of approximately 1.32 billion euros in 2024.
The transaction was complex and required the approval of the Federal Ministry of Labour and Economy in accordance with the Investment Control Act as well as the structured coordination of several international stakeholders. Thanks to their in-depth understanding of the subject matter and with the involvement of the key players, the DORDA experts were nevertheless able to complete the process under the Investment Control Act in record time. RetInSight's previous key personnel will remain with the company and will continue to be active in key functions.